Arcturus Therapeutics Holdings Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · San Diego, CA
ARCT chart
What traders are saying about $ARCT
Latest postsArcturus Therapeutics Holdings Inc. news
- Arcturus Therapeutics Holdings Inc. (ARCT) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 5, 2026
Yahoo Finance ·
- Arcturus Therapeutics (ARCT) Institutional Ownership 2026 $ARCT
MarketBeat ·
- Arcturus Therapeutics Holdings Inc. Estimates – NASDAQ:ARCT
TradingView ·
- Are Medical Stocks Lagging Agilon Health (AGL) This Year?
Yahoo Finance ·
- Arcturus Therapeutics unveils LUNAR 2.0 lipid delivery system and updates OTC deficiency program
Traders Union ·
- 4 RNA Therapeutics Stocks Leading the Next Wave of Innovation
Yahoo Finance ·
- Arcturus Highlights ARCT-810 Phase II Data, Unveils Next-Gen OTC Therapy Platform
marketbeat.com ·
- CoreWeave upgraded, Etsy downgraded: Wall Street's top analyst calls
Yahoo Finance ·
- Arcturus Therapeutics Announces Interim OTC Deficiency Phase 2 Results and Introduces LUNAR 2.0™ Next-Generation mRNA Delivery Platform
Yahoo Finance ·
- Arcturus Therapeutics to Present Ornithine Transcarbamylase (OTC) Deficiency Phase 2 Clinical Data and Provide Update on mRNA Liver Therapeutics Platform
Yahoo Finance ·
- Arcturus Therapeutics to Participate in Upcoming Investor Conferences
Yahoo Finance ·
Arcturus Therapeutics Holdings Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $82.0M | $152.3M | $166.8M | $206.0M |
| Net income | -$65.8M | -$80.9M | -$29.7M | $9.3M |
| Diluted EPS | $-2.40 | $-3.00 | $-1.12 | $0.35 |
| Total assets (year end) | $271.1M | $344.1M | $429.4M | $450.4M |
| Cash and equivalents (year end) | $230.9M | $237.0M | $292.0M | $391.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 8-KCurrent report (material event)
- 8-KCurrent report (material event)
- 10-Q10-Q
- 8-KCurrent report (material event)
- 8-KCurrent report (material event)
- 8-KCurrent report (material event)
- 10-Q10-Q
- 8-KCurrent report (material event)
- DEF 14AProxy statement
- 10-K10-K
- 8-KCurrent report (material event)
- 8-KCurrent report (material event)
About Arcturus Therapeutics Holdings Inc.
- Ticker
- ARCT (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1768224
Frequently asked questions
What exchange is Arcturus Therapeutics Holdings Inc. listed on?
Arcturus Therapeutics Holdings Inc. trades on the Nasdaq under the ticker symbol ARCT.
What industry is Arcturus Therapeutics Holdings Inc. in?
Arcturus Therapeutics Holdings Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Arcturus Therapeutics Holdings Inc. headquartered?
Arcturus Therapeutics Holdings Inc.'s business address on file with the SEC is in San Diego, CA.
When does Arcturus Therapeutics Holdings Inc.'s fiscal year end?
Arcturus Therapeutics Holdings Inc.'s fiscal year ends on December 31.
How much revenue did Arcturus Therapeutics Holdings Inc. report?
Arcturus Therapeutics Holdings Inc. reported $82.0M in revenue for calendar year 2025, according to its SEC filings.